Australian Pharmacists Support Providing Nonprescription Naloxone But Training Unavailable
Two studies revealed a lack of knowledge by pharmacists in Australia about providing naloxone despite being available without a prescription from pharmacists since 2016. Results could be an indication of potential problems if the opioid antagonist is made available nonprescription in US.
You may also be interested in...
In response to highest number of overdose deaths in US history in 2021, 30 members from both chambers of Congress sign letters sent to seven CEOs of naloxone manufacturers.
Opposition to making naloxone available OTC remains strident because of stigma surrounding drug overdoses, says Bobby Mukkamala, a head and neck surgeon and an AMA Board of Trustees member.
“A big part of our failure to stop overdose deaths is that the medical and public health establishment cannot reach the populations at greatest risk of overdose,” says overdose prevention researcher Nabarun Dasgupta.